Alora Pharmaceuticals, Llc
Alora Pharmaceuticals, Llc (United States) has no DMF, CEP or site registration linked in our records. 40 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Alora Pharmaceuticals, Llc: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/alora-pharmaceuticals-llc
Overview
Alora Pharmaceuticals, Llc is a pharmaceutical company headquartered in Alpharetta, United States.
FDA compliance signals
40 FDA enforcement records linked to this company.
- warning_letter2025-09-09
FDA Warning Letter (drug product)
- 4832024-12-18
Late submission of annual safety reports
- 4832024-12-18
Late submission of quarterly safety reports
- 4832024-12-18
Timely submission
- 4832023-11-08
Procedures not in writing, fully followed
- 4832023-11-08
Returned drug procedures in writing and followed
- 4832023-11-08
Investigations of discrepancies, failures
- 4832023-11-08
Control procedures to monitor and validate performance
- 4832023-02-10
Investigations of discrepancies, failures
- 4832023-02-10
Approve or reject procedures or specs
- 4832023-02-10
Procedures to be written and followed
- 4832023-02-10
Scientifically sound laboratory controls
- 4832021-09-17
Procedures to be written and followed
- 4832021-09-17
Approve or reject components, products
- 4832021-09-17
Investigations of discrepancies, failures
- 4832021-09-17
SOPs not followed / documented
- 4832021-09-17
Training , Education , Experience overall
- warning_letter2020-08-14
FDA Warning Letter (drug product)
- 4832019-03-29
Timely submission
- 4832019-03-29
Late submission of annual safety reports
- 4832017-03-08
Timely submission
- 4832017-03-08
Failure to develop written procedures
- 4832017-03-08
Interval
- 4832015-10-28
Procedures not in writing, fully followed
- 4832015-10-28
Storage under appropriate conditions
- 4832013-10-31
Items to cover on annual reviews
- 4832013-10-31
Test methods
- 4832013-10-31
Written record of investigation incomplete
- 4832013-10-31
Control procedures to monitor and validate performance
- 4832013-10-31
Responsible firm officials notified in writing
- 4832013-10-31
Contract drug products--lack of responsibility
- 4832013-10-31
Complaint Investigation/Follow-Up Findings
- 4832013-10-31
GMP Training Frequency
- 4832012-03-22
Returned drug procedures in writing and followed
- 4832012-03-22
Procedures not in writing, fully followed
- 4832012-03-22
Recall facilitation
- 4832010-04-02
Quality control unit review of records
- 4832010-04-02
Procedures not in writing, fully followed
- 4832010-04-02
SOPs not followed / documented
- 4832010-04-02
Written complaint record must include
Is this Alora Pharmaceuticals, Llc?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.